Clinical Trial Update: Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of HRS9531 injections in overweight or obese individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight or Obesity

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Overweight or Obesity | Phase 2 | Status: UNKNOWN